Research Topics
| Kavita NandaSummaryAffiliation: Family Health International Country: USA Publications
| Collaborators
|
Detail Information
Publications
Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic reviewK Nanda
Duke University Medical Center and Durham Veterans Affairs Medical Center, North Carolina 27705, USA
Ann Intern Med 132:810-9. 2000..To evaluate the accuracy of conventional and new methods of Papanicolaou (Pap) testing when used to detect cervical cancer and its precursors...- Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapyKavita Nanda
Family Health International, Research Triangle Park, North Carolina 27709, USA
Fertil Steril 90:965-71. 2008..To evaluate the effect of an antiretroviral (ARV) therapy regimen containing zidovudine (AZT), lamivudine (3TC), and efavirenz (EFV) on the pharmacokinetics of depot medroxyprogesterone acetate (DMPA)... 
Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and ThailandKavita Nanda
Behavioral and Biomedical Research Division, Family Health International, NC 27514, USA
Contraception 83:542-8. 2011..We examined hormonal contraceptive (HC) discontinuation and factors associated with discontinuation among HIV-uninfected women and the effect of HIV diagnosis on subsequent contraceptive use...- Quinacrine sterilization and gynecologic cancers: a case-control study in northern VietnamDavid C Sokal
Family Health International, Durham, NC 27713, USA
Epidemiology 21:164-71. 2010..Over 100,000 women worldwide have been sterilized by insertion of quinacrine into the uterus to induce tubal scarring. Concern has been expressed about possible carcinogenicity, and specifically the risk of uterine cancer... - Safety of quinacrine contraceptive pellets: results from 10-year follow-up in VietnamDavid C Sokal
Family Health International, Research Triangle Park, NC 27709, USA
Contraception 78:66-72. 2008..This study was conducted to evaluate long-term safety of quinacrine pellets for nonsurgical sterilization among women in Vietnam... - Contraceptive effectiveness of two insertions of quinacrine: results from 10-year follow-up in VietnamDavid C Sokal
Family Health International, Research Triangle Park, NC 27709, USA
Contraception 78:61-5. 2008..This study was conducted to evaluate the long-term effectiveness of two insertions of quinacrine pellets for nonsurgical sterilization among women in northern Vietnam... - Validation of a job aid to rule out pregnancy among family planning clients in NicaraguaJohn Stanback
Family Health International, Health Services Research, PO Box 13950, Research Triangle Park, NC 27709, United States of America
Rev Panam Salud Publica 23:116-8. 2008..Provider fears that nonmenstruating clients are pregnant are usually misplaced, while fears that hormonal methods can harm fetuses are exaggerated... - Do clinical experts rely on the Cochrane library?David A Grimes
Family Health International, Research Triangle Park, North Carolina 27709, USA
Obstet Gynecol 111:420-2. 2008..Although about one half of Clinical Expert Series articles cited relevant Cochrane reviews, most eligible reviews were not referenced. Wider use of Cochrane reviews could strengthen the scientific basis of this popular series... 
SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in NigeriaPaul J Feldblum
Family Health International, Research Triangle Park, North Carolina, USA
PLoS ONE 3:e1474. 2008..The objective of this trial was to determine the effectiveness of 1.0% C31G (SAVVY) in preventing male-to-female vaginal transmission of HIV infection among women at high risk...- Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trialMarkus J Steiner
Family Health International, PO Box 13950, Research Triangle Park, NC 27707, USA
Obstet Gynecol 101:539-47. 2003..To compare the contraceptive effectivenesses of a polyurethane condom and a standard latex condom. Secondary outcomes of interest were safety, functionality, discontinuation, and acceptability... - Magnesium sulfate tocolysis: time to quitDavid A Grimes
Family Health International, Research Triangle Park, North Carolina 27709, USA
Obstet Gynecol 108:986-9. 2006..Should tocolysis be desired, calcium channel blockers, such as nifedipine, seem preferable... - Fertility awareness-based methods for contraception: systematic review of randomized controlled trialsDavid A Grimes
Family Health International, Research Triangle Park, NC 27709, USA
Contraception 72:85-90. 2005..The efficacy and acceptability of these methods are unclear... - The Good Clinical Practice guideline: a bronze standard for clinical researchDavid A Grimes
Family Health International, Research Triangle Park, NC, USA
Lancet 366:172-4. 2005 - Steroid hormones for contraception in men: systematic review of randomized controlled trialsDavid A Grimes
Family Health International, P O Box 13950, Research Triangle Park, NC 27709, USA
Contraception 71:89-94. 2005..To avoid bias, future trials need to pay more attention on the methodological requirements for randomized controlled trials. Trials with adequate power would also be helpful... - Hormone replacement therapy and the risk of death from breast cancer: a systematic reviewKavita Nanda
Family Health International, Durham, NC, USA
Am J Obstet Gynecol 186:325-34. 2002..In a few studies, this risk reduction was attenuated after prolonged use or prolonged duration of follow-up. Limited information on recency of use, dose, or use of combined hormone replacement therapy was available... - Twenty micrograms vs. >20 microg estrogen oral contraceptives for contraception: systematic review of randomized controlled trialsMaria F Gallo
Family Health International, Research Triangle Park, NC 27709, USA
Contraception 71:162-9. 2005..While health care providers and women might select COCs containing 20 microg EE based on theoretical improvements in safety profile from the reduced dose of estrogen, no evidence is available to support this choice... - SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in GhanaLeigh Peterson
Family Health International, Durham, North Carolina, United States
PLoS ONE 2:e1312. 2007..The objective of this trial was to determine the effectiveness of 1.0% C31G (SAVVY) in preventing male-to-female vaginal transmission of HIV infection among women at high risk...